Sarepta Therapeutics(SRPT)
Focus: Sarepta Therapeutics is a Cambridge-based public biotech specializing in RNA-targeted therapeutics, primarily focused on rare genetic diseases like Duchenne Muscular Dystrophy (DMD). The company operates at scale with 1,001–5,000 employees and maintains a strong R&D-first model.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
About Sarepta Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Sarepta Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Sarepta Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
1 imminent
VYONDYS 53
Hiring
Stable
Revenue
$1.2B
FY2025
Key Products
LOE Approaching
Help build intelligence for Sarepta Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.